I work in the Policy and Campaigns at Breast Cancer Now.
We’re currently responding to an assessment by the National Institute for Health and Care Excellence (NICE) into the drug treatment pembrolizumab (also known as Keytruda) in combination with chemotherapy for untreated secondary or locally recurrent inoperable triple negative breast cancer. This process will decide whether this treatment can be made available on the NHS.
We want to hear from people with experience of this treatment to help shape what we say to NICE about this treatment.
If you would like to share your experiences with us, please get in touch through our tell us your story form by 18th December.